Diagnostic accuracy of novel blood-biomarkers for Parkinson's disease

• Conditions: Parkinson; Parkinson's disease; 10028037

• Registration Number: NL-OMON56654
• Lead Sponsor: Radboud Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 July 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

- Subject is an adult, at least 18 years of age.
- Subject can read and understand Dutch.
- Subject has completed CMO-approved Informed Consent.
- Subject is willing, competent, and able to comply with all aspects of the
protocol, including biospecimen collections.

Exclusion Criteria

- Subject is pregnant or breastfeeding.
- Subject has Parkinson*s disease.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Minimal clinical data extracted from questionnaires and storage of patient<br /><br>material (cells, serum, plasma, DNA, RNA).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>